AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate

COVID-19 is a novel disease caused by SARS-CoV-2 which has conquered the world rapidly resulting in a pandemic that massively impacts our health, social activities, and economy. It is likely that vaccination is the only way to form “herd immunity” and restore the world to normal. Here we developed a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Vaccines (Basel)
Main Authors: Liu, Xuelan, Chang, Xinyue, Rothen, Dominik, Derveni, Mariliza, Krenger, Pascal, Roongta, Salony, Wright, Edward, Vogel, Monique, Tars, Kaspars, Mohsen, Mona O., Bachmann, Martin F.
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8073683/
https://ncbi.nlm.nih.gov/pubmed/33921677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9040403
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki